logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Ipilimumab/nivolumab/vancomycinVarious toxicities and off label use: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2023年 / 1947卷 / 1期
关键词:
D O I:
10.1007/s40278-023-35381-x
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:241 / 241
相关论文
共 50 条
  • [31] AntineoplasticsVarious toxicities and off label use: case report
    Reactions Weekly, 2023, 1960 (1) : 55 - 55
  • [32] Ipilimumab/NivolumabLack of efficacy and off label use : case report
    Reactions Weekly, 2024, 2019 (1) : 229 - 229
  • [33] Cefepime/vancomycinVarious toxicities: case report
    Reactions Weekly, 2017, 1645 (1) : 80 - 80
  • [34] Dexamethasone/vancomycinVarious toxicities: case report
    Reactions Weekly, 2021, 1847 (1) : 171 - 171
  • [35] Antineoplastics/vancomycinVarious toxicities: case report
    Reactions Weekly, 2017, 1673 (1) : 54 - 54
  • [36] Baclofen/vancomycinVarious toxicities: case report
    Reactions Weekly, 2020, 1793 (1) : 93 - 93
  • [37] Antineoplastics/vancomycinVarious toxicities: case report
    Reactions Weekly, 2021, 1860 (1) : 63 - 63
  • [38] Dasatinib/vancomycinVarious toxicities: case report
    Reactions Weekly, 2021, 1840 (1) : 146 - 146
  • [39] Ipilimumab/nivolumab/pembrolizumabVarious toxicities and lack of efficacy: case report
    Reactions Weekly, 2022, 1917 (1) : 328 - 328
  • [40] Ipilimumab/nivolumab/pembrolizumabVarious toxicities and drug ineffectiveness: case report
    Reactions Weekly, 2024, 2037 (1) : 223 - 223
← 12345 →